EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations

Giorgio Di Paco iD, Marina Macchiagodena iD, Piero Procacci iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Giorgio Di Paco und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Chimica "Ugo Schiff", Universit'a degli Studi di Firenze, Via della Lastruccia 3, 50019, Sesto Fiorentino, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, Molecular Docking Simulation, SARS-CoV-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ISCRA, MUR, National Recovery and Resilience Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have assembled a computational pipeline based on virtual screening, docking techniques, and nonequilibrium molecular dynamics simulations, with the goal of identifying possible inhibitors of the SARS‐CoV‐2 NSP13 helicase, catalyzing by ATP hydrolysis the unwinding of double or single‐stranded RNA in the viral replication process inside the host cell. The druggable sites for broad‐spectrum inhibitors are represented by the RNA binding sites at the 5’ entrance and 3’ exit of the central channel, a structural motif that is highly conserved across coronaviruses. Potential binders were first generated using structure‐based ligand techniques. Their potency was estimated by using four popular docking scoring functions. Common docking hits for NSP13 were finally tested using advanced nonequilibrium alchemical techniques for binding free energy calculations on a high‐performing parallel cluster. Four potential NSP13 inhibitors with potency from submicrimolar to nanomolar were finally identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsMolecular Docking SimulationSARS-CoV-2HumansBinding SitesDrug DesignEnzyme InhibitorsLigandsMethyltransferasesMolecular Dynamics SimulationRNA HelicasesViral Nonstructural Proteins

Stichwörter der Autor:innen

HelicaseNSP13 inhibitionSARS-CoV-2binding free energydrug designmolecular dynamics

Substanzen

Antiviral AgentsEnzyme InhibitorsLigandsMethyltransferasesNsp13 protein, SARS-CoVRNA HelicasesViral Nonstructural Proteins

Autor:innen und Institutionen

  • Dipartimento di Chimica "Ugo Schiff", Universit'a degli Studi di Firenze, Via della Lastruccia 3, 50019, Sesto Fiorentino, Italy.

ORCID-Profile: Giorgio Di Paco, Marina Macchiagodena, Piero Procacci

Förderung

  • ISCRA
  • MUR
  • National Recovery and Resilience Plan
  • Ministero dell'Università e della Ricerca

Zitieren

APA

Di Paco, G., Macchiagodena, M., & Procacci, P. (2024). Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations. ChemMedChem. https://doi.org/10.1002/cmdc.202400095

Vancouver

Di Paco G, Macchiagodena M, Procacci P. Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations. ChemMedChem. 2024. doi:10.1002/cmdc.202400095

BibTeX
@article{DiPaco2024,
  author = {Di Paco, Giorgio and Macchiagodena, Marina and Procacci, Piero},
  title = {Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400095}
}
Kostenlos starten →